Search results

Home Get involved People and communities - putting you at the heart of our work {"@context":"http://schema.org","@type":"BreadcrumbList","itemLis

Virtual wards (also known as hospital at home) provide hospital level care at home.

This NICE resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.

See a complete list of all our guidance and quality standards currently open for consultation

Find out what guidance is being considered for development

View a complete list of all our guidance, NICE advice and quality standards currently in development

Evidence-based recommendations on Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care.

Result type

HealthTech guidance

Published

27 January 2022

Evidence-based recommendations on Alpha-Stim AID for managing anxiety disorders.

Result type

HealthTech guidance

Published

8 March 2021

Evidence-based recommendations on the ReCell Spray-On Skin system for treating skin loss, scarring and depigmentation after burn injury.

Result type

HealthTech guidance

Published

12 November 2014

Evidence-based recommendations on the E-vita open plus for treating complex aneurysms and dissections of the thoracic aorta.

Result type

HealthTech guidance

Last updated

1 October 2018

Evidence-based recommendations on Kinesia 360 and KinesiaU (Great Lakes NeuroTechnologies), PDMonitor (PD Neurotechnology), Personal KinetiGraph (Global Kinetics) and STAT-ON (Sense4care) for remote monitoring of Parkinson’s disease.

Result type

HealthTech guidance

Last updated

25 January 2024

Evidence-based recommendations on placental growth factor (PLGF)-based testing to help diagnose suspected preterm pre-eclampsia. The tests are: DELFIA Xpress PLGF 1-2-3, DELFIA Xpress sFlt-1/PLGF 1-2-3 ratio, Elecsys immunoassay sFlt-1/PLGF ratio, Triage PLGF Test.

Result type

HealthTech guidance

Published

27 July 2022

Evidence-based recommendations on enzyme-linked immunosorbent assay (ELISA) tests for therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors in rheumatoid arthritis. The tests are Promonitor, IDKmonitor, LISA-tracker, RIDASCREEN, MabTrack, and those used by Sanquin Diagnostic Services.

Result type

HealthTech guidance

Published

10 July 2019

Evidence-based recommendations on therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors (LISA-TRACKER, IDKmonitor and Promonitor ELISA kits) in people with Crohn’s disease.

Result type

HealthTech guidance

Published

17 February 2016

Evidence-based recommendations on the My5-FU assay for measuring levels of 5-flurouracil (5-FU) in patients having chemotherapy, to help guide changes to the dose of 5-FU.

Result type

HealthTech guidance

Published

10 December 2014